JPRN-UMIN000013757已完成未知
Prospective observational study on anti-CCP antibody titer and clinical effect of abatacept (orencia) on patients with rheumatoid arthritis -A pilot study- - FRABR-ABT02
Fukuoka Rheumatoid Arthritis Biologics Registry (FRABR)0 个研究点目标入组 50 人开始时间: 2014年4月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with history of hypersensitivity to the content of abatacept. 2) Patients with severe infection. 3) Any other patients who are regarded as unsuitable for this study by the investigators
研究者
相似试验
已完成
不适用
Antibody response to COVID-19 in health care workersCTRI/2020/07/026837Ortho Clinical Diagnostics
招募中
不适用
Cohort study of immune-checkpoint-inhibitor antibody treatment in non-small-cell lung cancernon-small-cell lung cancerJPRN-UMIN000020719Saitama Medical University International Medical Center100
尚未招募
不适用
Observational study of COVID-19 prophylactic antibody administration in immunosuppressed patientsNeoplasmsKCT0007617lsan Univeristy Hospital100
已完成
不适用
A prospective observational study of immune-checkpoint inhibitor (Nivolumab) treatment in patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000021600Kitasato University School of Medicine52
进行中（未招募）
1 期
Effectivity of COVID-19 vaccination in people with Down syndromeEUCTR2021-002613-34-NLniversity Medical Center Utrecht640